Brevan Howard Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Buy
20,888
+6,427
+44% +$33.8K ﹤0.01% 1984
2026
Q1
$60.4K Buy
+14,461
New +$69.6K ﹤0.01% 2073
2025
Q3
– Sell
-29,877
Closed -$120K – 1955
2025
Q2
$120K Buy
+29,877
New +$97.2K ﹤0.01% 1773
2024
Q2
– Sell
-20,340
Closed -$58K – 1076
2024
Q1
$58K Buy
+20,340
New +$62.8K ﹤0.01% 932

Other funds holding SRTA

Brevan Howard Capital Management's SRTA Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Strata Critical Medical Inc (SRTA) stake by 44% in Q2 2026, buying an estimated $33.8K and bringing the position to 20,888 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Brevan Howard Capital Management first reported a position in SRTA in Q1 2024 and has held it in 4 quarters since. The position peaked at $120K in Q2 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Brevan Howard Capital Management held 20,888 shares of Strata Critical Medical Inc worth $110K as of Q2 2026.
  • Brevan Howard Capital Management bought 6,427 Strata Critical Medical Inc shares in Q2 2026, an estimated $33.8K.
  • Strata Critical Medical Inc made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1984 holding.
  • Brevan Howard Capital Management first reported a position in Strata Critical Medical Inc in Q1 2024 and has held it in 4 quarters since.
  • Brevan Howard Capital Management's Strata Critical Medical Inc position peaked at $120K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.